RIBUS awarded Gemini Pharmaceuticals with an Early Adopter Award for producing more than a thousand SKUs using RIBUS’ clean label excipients. (from left to right: Mike Finamore, CEO of Gemini Pharmaceuticals & Steve Peirce, President of RIBUS). Photo credit: Byron Mason
RIBUS awarded Gemini Pharmaceuticals with an Early Adopter Award for producing more than a thousand SKUs using RIBUS’ clean label excipients. (from left to right: Mike Finamore, CEO of Gemini Pharmaceuticals & Steve Peirce, President of RIBUS). Photo credit: Byron Mason